Schedule 13D ownership disclosure

SYNTA PHARMACEUTICALS CORP

Security class unavailable · CUSIP: 87162T206

Event date: 2015-12-03

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-15-008566
Form type
SC 13D/A
Filer
CAXTON CORP
CIK
CIK 1388551
Filed
Dec 07, 2015
Reporting period
Dec 03, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub